Unknown

Dataset Information

0

Quantifying hyperoxia-mediated damage to mammalian respiratory cilia-driven fluid flow using particle tracking velocimetry optical coherence tomography.


ABSTRACT: Oxygen supplementation [hyperoxia, increased fraction of inspired oxygen (FiO 2 )] is an indispensable treatment in the intensive care unit for patients in respiratory failure. Like other treatments or drugs, hyperoxia has a risk-benefit profile that guides its clinical use. While hyperoxia is known to damage respiratory epithelium, it is unknown if damage can result in impaired capacity to generate cilia-driven fluid flow. Here, we demonstrate that quantifying cilia-driven fluid flow velocities in the sub-100??m/s regime (sub-0.25 in./min regime) reveals hyperoxia-mediated damage to the capacity of ciliated respiratory mucosa to generate directional flow. Flow quantification was performed using particle tracking velocimetry optical coherence tomography (PTV-OCT) in ex vivo mouse trachea. The ability of PTV-OCT to detect biomedically relevant flow perturbations in the sub-100??m/s regime was validated by quantifying temperature- and drug-mediated modulation of flow performance in ex vivo mouse trachea. Overall, PTV-OCT imaging of cilia-driven fluid flow in ex vivo mouse trachea is a powerful and straightforward approach for studying factors that modulate and damage mammalian respiratory ciliary physiology.

SUBMITTER: Gamm UA 

PROVIDER: S-EPMC4874052 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Quantifying hyperoxia-mediated damage to mammalian respiratory cilia-driven fluid flow using particle tracking velocimetry optical coherence tomography.

Gamm Ute A UA   Huang Brendan K BK   Syed Mansoor M   Zhang Xuchen X   Bhandari Vineet V   Choma Michael A MA  

Journal of biomedical optics 20150801 8


Oxygen supplementation [hyperoxia, increased fraction of inspired oxygen (FiO 2 )] is an indispensable treatment in the intensive care unit for patients in respiratory failure. Like other treatments or drugs, hyperoxia has a risk-benefit profile that guides its clinical use. While hyperoxia is known to damage respiratory epithelium, it is unknown if damage can result in impaired capacity to generate cilia-driven fluid flow. Here, we demonstrate that quantifying cilia-driven fluid flow velocities  ...[more]

Similar Datasets

| S-EPMC3130586 | biostudies-other
| S-EPMC5018123 | biostudies-literature
| S-EPMC4574676 | biostudies-literature
| S-EPMC5430809 | biostudies-literature
| S-EPMC7401960 | biostudies-literature
| S-EPMC6640822 | biostudies-literature
| S-EPMC8572508 | biostudies-literature
| S-EPMC4102363 | biostudies-other
| S-EPMC4806300 | biostudies-literature
| S-EPMC5115969 | biostudies-literature